Solv Rounds up $45M in C Round

Launched in 2021, the NKF Innovation Fund works to accelerate funding, development, and commercialization of therapies that kidney patients need and deserve. The fund invests in early to mid-stage companies that are developing innovative, patient-centric kidney therapies.

NEA led the equity funding.

This funding followed 24% growth year-over-year, the company said.

Medix operates 21 offices across the U.S. with operations in 44 states.